中国科技核心期刊
中国科技论文统计源期刊
中文生物医学期刊文献数据库
中国科学引文数据库(CSCD收录)
中国学术期刊综合评价数据库统计源期刊
《中国学术期刊影响因子年报》统计源期刊
Chinese Journal of Blood Purification ›› 2023, Vol. 22 ›› Issue (1): 52-55.doi: 10.3969/j.issn.1671-4091.2023.01.012
Previous Articles Next Articles
RUAN Yi-lin, XU Tian, REN Hong
Received:
Revised:
Online:
Published:
Contact:
Abstract: Calprotectin (S100A8/A9) is a Ca2+ binding protein in the S100 protein family, having a wide range of biological activities and serving as a biomarker for many diseases. Peritoneal dialysis-related peritoneal fibrosis is one of the common complications in peritoneal dialysis (PD) patients. Many studies have recently proved that S100A8/A9 plays an important part in the development of peritoneal fibrosis. Our previous study also confirms that S100A8/A9 is up-regulated in peritoneal fibrosis and down-regulated after inhibition of peritoneal fibrosis. This article discusses the prospect of S100A8/A9 as a new target for the diagnosis and treatment of peritoneal fibrosis.
Key words: S100A8/A9, Peritoneal fibrosis, Peritoneal dialysis
CLC Number:
R459.5
RUAN Yi-lin, XU Tian, REN Hong. Investigation on calprotectin as a new target for the diagnosis and treatment of peritoneal dialyis-related peritoneal fibrosis[J]. Chinese Journal of Blood Purification, 2023, 22(1): 52-55.
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: https://www.cjbp.org.cn/EN/10.3969/j.issn.1671-4091.2023.01.012
https://www.cjbp.org.cn/EN/Y2023/V22/I1/52